Literature DB >> 26607185

Guillain-Barré syndrome as first presentation of systemic lupus erythematosus: a rare manifestation complicated by IVIg-induced splenic infarct.

Richard M Fazio1, Ioana Chen1, Navjot Somal1.   

Abstract

A 44-year-old woman presented with progressively worsening neurological symptoms of 1 week duration. Physical examination revealed absent reflexes of the lower extremities and proximal muscle weakness, bilaterally. Cerebrospinal fluid analysis and electrophysiological studies were consistent with the diagnosis of Guillain-Barré syndrome (GBS) and the patient was started on intravenous immunoglobulin infusion. Along with positive neurological findings, rheumatological work up revealed elevated antinuclear antibody titres, positive double-stranded DNA and anti-Smith antibodies. These results, in conjunction with positive clinical findings, confirmed an underlying diagnosis of systemic lupus erythematosus (SLE). The patient's hospital course was complicated by an episode of severe left upper quadrant abdominal pain, fever, tachycardia and elevated inflammatory markers. CT scan of the abdomen revealed a splenic infarct following completion of IVIg infusion, making this a contributor to thrombus formation in the setting of an already thrombophilic state, and a rare complication of an approved method of treatment. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26607185      PMCID: PMC4680246          DOI: 10.1136/bcr-2015-211598

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

Review 3.  Significance of IgA antiphospholipid antibodies.

Authors:  W A Wilson; Z Faghiri; F Taheri; A E Gharavi
Journal:  Lupus       Date:  1998       Impact factor: 2.911

4.  High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.

Authors:  D Fanopoulos; M R Teodorescu; J Varga; M Teodorescu
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

Review 5.  Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.

Authors:  I Marie; G Maurey; F Hervé; M-F Hellot; H Levesque
Journal:  Br J Dermatol       Date:  2006-10       Impact factor: 9.302

6.  Association of IgA Anti-beta2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus.

Authors:  Taraneh Mehrani; Michelle Petri
Journal:  J Rheumatol       Date:  2010-10-15       Impact factor: 4.666

7.  Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R A C Hughes; E F M Wijdicks; R Barohn; E Benson; D R Cornblath; A F Hahn; J M Meythaler; R G Miller; J T Sladky; J C Stevens
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

8.  Systemic lupus erythematosus and acute demyelinating polyneuropathy.

Authors:  M G Robson; M J Walport; K A Davies
Journal:  Br J Rheumatol       Date:  1994-11

9.  A case of systemic lupus erythematosus presenting as Guillain-Barré syndrome.

Authors:  K R Chaudhuri; I K Taylor; R M Niven; R J Abbott
Journal:  Br J Rheumatol       Date:  1989-10

10.  Neuropsychiatric systemic lupus erythematosus.

Authors:  Alexandra Popescu; Amy H Kao
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

View more
  4 in total

1.  Fulminant Guillain-Barré syndrome in a patient with systemic lupus erythematosus.

Authors:  Eric Anthony Coomes; Hourmazd Haghbayan; Jenna Spring; Sangeeta Mehta
Journal:  BMJ Case Rep       Date:  2019-01-14

2.  Neuropsychiatric Lupus: The Devil is in the Detail.

Authors:  Arunmozhimaran Elavarasi; Mamta B Singh; Padma Srivastava; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2019 Apr-Jun       Impact factor: 1.383

3.  Guillain-Barré syndrome occurring synchronously with systemic lupus erythematosus as initial manifestation treated successfully with low-dose cyclophosphamide.

Authors:  Naveed Ali; Ritesh Rampure; Faizan Malik; Syed Imran Mustafa Jafri; Deepa Amberker
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-04-25

4.  The introspection on the diagnosis and treatment process of a case of Guillain-Barré syndrome (GBS) attributed to systemic lupus erythematosus (SLE): A case report.

Authors:  Nan Zhang; Jie Cao; Meng Zhao; Li Sun
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.